17 articles
Comprehensive overview of HRT options, administration methods, and clinical considerations for treating menopausal symptoms and preventing osteoporosis.
A case-based clinical guide addresses gender-affirming hormone therapy alongside dementia, heart disease, prostate cancer, and bone loss in older TGD adults.
New comprehensive review reveals timing, route, and dose dramatically affect hormone therapy safety and effectiveness for menopause symptoms.
New research reveals obesity worsens menopause symptoms and hormone therapy risks, calling for integrated treatment approaches.
International endocrinology conference highlights cutting-edge treatments for diabetes, obesity, thyroid disease, and hormonal disorders.
New clinical guidance emphasizes obesity treatment as essential for comprehensive menopause care and long-term health outcomes.
A new clinical framework helps identify dangerous causes of excess androgens in postmenopausal women, from tumors to genetic syndromes.
New research shows combining weight-loss medications with hormone therapy could transform health outcomes for obese men with low testosterone.
Combining resistance training, Mediterranean diet, and plant compounds offers safe alternatives to hormone replacement therapy.
Multidisciplinary consensus addresses menopausal hormone therapy decisions for breast cancer survivors through shared decision-making framework.
A biomarker-guided treatment strategy outperforms traditional stepwise therapy, achieving hormonal control in nearly 80% of acromegaly patients.
ASTER 70s trial compares treatment intensities for women 70+ with genomically high-risk breast cancer to optimize outcomes while minimizing toxicity.
A 510-woman pilot study finds transdermal testosterone significantly improves mood, cognition, and libido after just 4 months.
German registry reveals physicians start most patients on lower-than-recommended doses of new long-acting growth hormone therapies.
Scientists respond to methodological concerns about testosterone therapy research in transgender men, addressing study design questions.
First study tracking DNA methylation aging clocks during transgender hormone therapy reveals treatment-specific patterns.
New analysis shows adrenalectomy more effective than drugs at reducing dangerous heart muscle thickening in primary aldosteronism patients.
